Document is current

Article History

Received: 13 May 2026

Accepted: 12 June 2026

First Online: 25 June 2026

Declarations

Conflict of interest: Kacie H Denton: Reports no conflicts of interest. Chris C Slaughter: Reports no conflicts of interest. Audrey Bennett: Reports consulting fees from Celltrion, which is unrelated to this work. Elizabeth A Scoville: Reports no conflicts of interest. Robin L Dalal: Reports consulting fees from Abbvie, which is unrelated to this work. Sara Horst: Reports consulting fees from Abbvie, Takeda, Biocon, Pfizer, and Johnson & Johnson, and educational grant support from Abbvie and Takeda, all of which are unrelated to this work. Dawn B Beaulieu: Reports consulting fees from Abbvie, Takeda, Johnson & Johnson, Zymfentra, and Institute of Functional Medicine, all of which are unrelated to this work. David A Schwartz: Reports consulting fees from Abbvie, Janssen, Takeda, Avbios, Olympus, all of which are unrelated to this work. Baldeep S Pabla: Reports consulting fees from Abbvie, advisory board fees from Johnson & Johnson, Astellas, and Bristol Myers Squibb, and speaker fees from Prometheus, Eli Lilly, all of which are unrelated to this work.

Ethical approval: The study received approval from the VUMC Institutional Review Board in January 2025. A standardized electronic consent form, approved for use at VUMC, was embedded within the survey and required completion before completion of the survey. All participants were informed that their involvement was entirely voluntary and that they could withdraw from the study at any time without consequence. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

Consent to participate: A standardized electronic consent form, approved for use at VUMC, was embedded within the survey and required completion before completion of the survey. All participants were informed that their involvement was entirely voluntary and that they could withdraw from the study at any time without consequence.